(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's ...
GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...
12d
GlobalData on MSNGSK and UK researchers plan to study Shingrix and dementia risk reduction linkThe study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
GSK plc (LSE/NYSE: GSK) today announced a major new research collaboration with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to advance understanding of ...
GSK (GSK) plc announced a new research collaboration with the UK Dementia Research Institute and Health Data Research UK to advance ...
GSK, UK Dementia Research Institute and Health Data Research UK to collaborate on first-of-its-kind dementia research initiative: London, UK Thursday, March 27, 2025, 09:00 Hrs [I ...
GSK has announced a partnership with the UK Dementia Research Institute and Health Data Research UK to explore a potential ...
GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I'd seen in the stock before that.
FTSE 100 p harma giants GSK and Astrazeneca may have escaped the worst of US President Donald Trump’s tariffs, according to a ...
GSK (GSK) is pushing the UK government to give pharmaceutical companies more access to its public health data in order to accelerate drug ...
GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results